14 Placental alkaline phosphatase has been observed in isolated or small groups of tumor cells.
What does PAP stand for?
PAP stands for Placental Alkaline Phosphatase (biology)
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of PAP
Other Resources:
We have 456 other meanings of PAP in our Acronym Attic
- Abbreviation Database Surfer
- « Previous
- Next »
- Personnel Assurance Program
- Peruvian Aprista Party
- Pharmaceutical Assistance Program (various locations)
- Pharmacy Administration and Practice
- Pharmacy Assistance Program
- Philosophical Association of the Philippines (Philippines)
- Phosphatidic Acid Phosphatase
- Physical Activity Program (various locations)
- Physician Assistant Program (various locations)
- Picture and Picture
- Plant Administrative Procedure
- Plasma Arc Pyrolysis
- Poker Affiliate Program (gambling)
- Police Accountability Project (University of Chicago; Illinois)
- Policy Administration Point (identity governance)
- Policy Advisory Panel (various organizations)
- Policy Agendas Project (University of Texas at Austin)
- Polska Agencja Prasowa (Polish News Agency)
- Poluautomatska Puška (Croatian: semi-automatic rifle)
- Polyaspartic Aliphatic Polyurea (concrete sealer)
Samples in periodicals archive:
Placental alkaline phosphatase is higher in cord blood of cases with labor than those without it (4), suggesting that labor increases transplacental maternal-fetal microtransfusion.
The diagnosis of seminoma was confirmed by further immunohistochemical studies (figure 2, C), although the negative staining for placental alkaline phosphatase and CD 117 are considered to be atypical for seminoma.
The antibodies used were specific for CD45RB (leukocyte common antigen; 1:300, Dako Corporation, Carpinteria, Calif), CD3 (1:150, Dako), CD20 (L26; 1:700, Dako), CD79a (1:50, Dako), [Kappa] immunoglobulin light chain (1:10000, Dako), [Lambda] immunoglobulin light chain (1:10000, Dako), Bcl-6 (1: 10, Dako), epithelial membrane antigen (1:25, Dako), CD10 (1:70, Vector, Burlingame, Calif), CD30 (1:20, Signet, Dedham, Mass), Bcl-2 (1:200, BioGenex, San Ramon, Calif), Ki-67 (1:20, Beckmann Coulter, Miami, Fla), keratin (AE1/AE3; 1:500, Boehringer Mannheim, Indianapolis, Ind), [Alpha]-fetoprotein (1:25, Zymed Lab, San Francisco, Calif), and placental alkaline phosphatase (1:20, Lab Vision Corp, Freemont, Calif).
The antibodies used included S100 protein (polyclonal), desmin (D33), carcinoembryonic antigen (polyclonal), chromogranin A, [Alpha]-1-fetoprotein (polyclonal), glial fibrillary acidic protein (GFAP, 6F2), and placental alkaline phosphatase (polyclonal; all from Dakopatts, Glostrup, Denmark); CD34 (QBend 10, Serotec, Washington, DC); pancytokeratin (AE1/AE3, Boehringer, Mannheim, Germany); [Alpha]-smooth muscle actin (1A4, Sigma, St Louis, Mo); muscle-specific actin (HHF-35, Enzo Diagnostic, New York, NY); CD99 (O13, Signet, Dedham, Mass), [Alpha]-inhibin (RI, Serotec, Oxford, England); estrogen receptor (ER1D5, Dakopatts), and progesterone receptor (PR10A9, Immunotech, Marseille, France).